Red Glead Discovery is a leading and sustainable Scandinavian Drug Discovery Partner with experienced co-workers and with a focus on small molecule- and peptide-based therapeutics. Our research platform comprises medicinal chemistry, synthesis, computational science, biology, ADME and fragment-based lead discovery (WAC™, DSF, and NMR), enabling tailored customer projects. High-quality in vivo PK/pharmacology, X-ray crystallography and cellular target engagement services are available for integrated projects via trusted and often local partners. Our track record contains several examples of successful collaborations with customers from hit finding and lead discovery up to delivery of candidate compounds progressed into preclinical and clinical development.
